A Coordinated Translational Control Mediated by eEF2 Phosphorylation Safeguards Erythroid Differentiation
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104801 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yao Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, Shanghai Institute of Immunology, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, Chin…. Hauptthemen laut MEDLINE: Erythropoiesis, Protein Biosynthesis, Cell Differentiation, Erythroid Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Shanghai Science and Technology Commission, National Natural Science Foundation Projects of China.
Abstract (Originalsprache)
Translational control is crucial for maintaining cellular homeostasis, yet the distinct features and regulatory requirements governing protein synthesis during erythropoiesis remain unclear. Here, we reveal that erythroid cells exhibit an extraordinarily high demand for protein synthesis, which is required for their differentiation but also implies the need for tight regulation to prevent excessive erythropoiesis. Notably, we identify significant phosphorylation of eukaryotic elongation factor 2 (eEF2) at threonine 56 during erythroid differentiation, which reduces protein synthesis and acts as a molecular brake to limit unchecked erythropoiesis. This is evidenced by elevated red blood cell counts in peripheral blood and increased incidence of blood hyperviscosity and thrombosis in eEF2_T56M mice, which are deficient in eEF2 phosphorylation. Mechanistic studies demonstrate that eEF2 phosphorylation selectively regulates the translation of a subset of proteins, including NFE2, which partially mediates the effects of eEF2 modification. Collectively, our findings highlight a previously unappreciated role for translational control in achieving efficient and balanced erythropoiesis, with eEF2 phosphorylation serving as a critical protective mechanism against hyperactive erythropoiesis and offering a potential therapeutic target for hematologic disorders such as polycythemia vera.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, Shanghai Institute of Immunology, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China.
- Shanghai Key Laboratory of Embryo Original Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
- State Key Laboratory of Systems Medicine for Cancer, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China.
ORCID-Profile: Cuiping Yang, Zhiduo Liu
Förderung
- National Key Research and Development Program of China
- Shanghai Science and Technology Commission
- National Natural Science Foundation Projects of China
- Program of Shanghai Academic/Technology Research Leader
- Opening Project of Shanghai Key Laboratory of Embryo Original Diseases
- Opening Project of the Shanghai Key Laboratory of Embryo Original Diseases
Zitieren
APA
Ma, Y., Song, H., Liu, S., Yu, W., Feng, G., Yang, C., & Liu, Z. (2025). A Coordinated Translational Control Mediated by eEF2 Phosphorylation Safeguards Erythroid Differentiation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104801
Vancouver
Ma Y, Song H, Liu S, Yu W, Feng G, Yang C, et al. A Coordinated Translational Control Mediated by eEF2 Phosphorylation Safeguards Erythroid Differentiation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104801
BibTeX
@article{Ma2025,
author = {Ma, Yao and Song, Haozhuo and Liu, Siming and Yu, Wenjing and Feng, Guanying and Yang, Cuiping and Liu, Zhiduo},
title = {A Coordinated Translational Control Mediated by eEF2 Phosphorylation Safeguards Erythroid Differentiation},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104801}
}
EUVIMED